Pubblicazioni

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19. a meta-analysis

2022 - HAEMATOLOGICA

Loffredo, Lorenzo; Di Castelnuovo, Augusto; Chiariello, Giovanni Alfonso; Pignatelli, Pasquale; Violi, Francesco

Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study

2022 - INTERNAL AND EMERGENCY MEDICINE

Squizzato, A.; Galliazzo, S.; Rancan, E.; Di Pilla, M.; Micucci, G.; Podda, G.; Valeriani, E.; Campiotti, L.; Bertu, L.; Ageno, W.; Porreca, E.; Lodigiani, C.

Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis

2022 - BLOOD ADVANCES

Candeloro, M.; Valeriani, E.; Monreal, M.; Ageno, W.; Riva, N.; Lopez-Reyes, R.; Peris, M. L.; Westendorf, J. B.; Schulman, S.; Rosa, V.; Lopez-Nunez, J. J.; Garcia-Pagan, J. -C.; Magaz, M.; Senzolo, M.; De Gottardi, A.; Nisio, M. D.

"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients-30 months follow-up": Comment from Serrao et al

2022 - JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Serrao, Alessandra; Assanto, Giovanni Manfredi; Malfona, Francesco; Chavez Orellana, Gabriela; Chistolini, Antonio